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Sulmonellu organisms occur worldwide and are respon- 
sible for a broad spectrum of clinical syndromes, 
including self-limited gastroenteritis, bacteremia and 
vascular infection, enteric fever, and metastatic focal 
infections, although infection may be asymptomatic.’ 
Here we report a case of subcutaneous abscess caused 
by multiresistant Salmonella senftenberg. 
A 62-year-old obese female presented with swelling 
of 1.5 days’ duration with multiple ulcers in the left lower 
limb. She had suffered intermittently with the same 
symptoms for 4 years, and had been diagnosed and 
operated on for varicose veins (left saphenofemoral 
junction ligation with great saphenous vein stripping 
and bilateral below-knee perforator ligation) in the same 
hospital 18 months previously. She had been a known 
type 2 diabetic patient for 8 years, and was on mixtard 
insulin twice daily (9 and 4 units). Local examination 
revealed diffuse, tender swelling, with multiple blebs and 
ulcers occupying the upper and lateral two-thirds of the 
left lower limb. Laboratory investigations done at the 
time of admission were within normal limits, except for 
a random blood glucose level of 480 mg/dL. 
S. senftenberg was isolated from the aspirated pus of 
the subcutaneous swelling. The isolate was an extended- 
spectrum B-lactamase (ESBL) producer by double disk 
synergy test, and was sensitive to trimethoprim-sulfa- 
methoxazole, amoxicillin-clavulanic acid and imipenem 
by the Kirby-Bauer disk diffusion method. Urine and 
blood cultures were sterile. Stool and repeat pus culture 
yielded S. senftenberg with a similar antibiotic suscepti- 
bility pattern. The Widal test was negative. The patient 
recovered well after specific antibiotic treatment, skin 
graft to close the wound, and diabetic management. 
There is a tendency for SuZmonellu species to localize 
in injured or damaged tissue or in sites of malignancy.2 
In the present case, the patient was diabetic and probably 
a carrier of S. senftenberg, with varicose veins, suffering 
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from repeated attacks of pruritic purulent dermatitis of 
the left lower limb, for which she was operated on. 
Previous trauma at the operative site is a risk factor, 
suggesting that hematomas may serve as a nidus for 
bacteremic seeding.i Perhaps operative trauma would 
have acted as the predisposing factor in the present 
case. In one series, patients with Salmonella soft tissue 
infections had pustular dermatitis or subcutaneous 
abscesses,* while in another series, most patients had 
underlying illnesses, such as malignancies, diabetes, trans- 
plants, burns, or sickle-cell disease.3 
S. senftenberg is an uncommon serotype and was 
first isolated in 1928. Recently, its increasing rate of 
isolation from human sources has suggested that it is 
an important pathogen. 4-6 A study in India, conducted 
between January 1994 and 1998, reported an 11.1% iso- 
lation rate of S. senftenberg from stool samples from 
gastroenteritis patients.4 Although hospital outbreak 
reports have been documented,5 we did not encounter 
any other cases with S. senftenberg in our hospital. ESBLs 
are also rarely associated with the genus Salmonella. 
The first report of SHV-5 p-lactamase in S. senftenberg 
from India came from an outbreak in a burns ward.5 
Although our isolate was an ESBL producer (pheno- 
typic confirmation) with multiresistance, we could not 
determine the type of ESBL. S. senftenberg infections, 
although rare, have recently been increasing in frequency 
in India. Perhaps isolation of an ESBL-producing Sal- 
monella strain should warn us of the possibility of S. 
senftenberg, and a possible outbreak in the hospital. 
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